Article info

Download PDFPDF
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies
  1. M Dastmalchi, Rheumatology, Unit, Karolinska University Hospital, Solna, SE-171 76 Stockholm, Sweden; maryam.dastmalchi{at}karolinska.se
View Full Text

Citation

Dastmalchi M, Grundtman C, Alexanderson H, et al
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies

Publication history

  • Accepted January 28, 2008
  • First published February 13, 2008.
Online issue publication 
November 12, 2008

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.